Herantis Pharma Oyj

HEL:HRTIS.HE

1.69 (EUR) • At close November 17, 2023
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) EUR.

2024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q42012 Q22011 Q42011 Q2
Omzet 000000000000000000.05100.0010.0010000000
Kosten van de omzet 0000000.08-0.080.4640.4640.4840.562001.21300.60400000000000
Brutowinst 000000-0.080.08-0.464-0.464-0.484-0.562000000.02500.0010.0010000000
Brutowinstmarge 000000000000000000.51110001100
Onderzoek- en ontwikkelingskosten 02.10.61.52.122.882.963.243.0282.31.7640.71.9281.11.6280.70.7641.24.9764.13.8190.5000000
Algemene en administratieve kosten 0000000000000000000000000000
Verkoop- en marketingkosten 0000000000000000000000000000
Verkoop-, algemene en administratieve kosten 2.8460.7660.4421.1881.4881.640.4812.3691.4951.3390.3282.4760.5620.6820.4490.5750.6430.5450.2830.7660.7600.054106.70.1910.1910.7160.716
Overige kosten -0.575-0.11-2.3230.280.1690.00301.2950.2990.4110.0230.113-0.1330.235-0.1340.1500-4.0418.8661.4371.1940.20300000
Bedrijfskosten 2.2712.756-2.5622.4083.4734.524.514.544.5233.5493.7452.3642.3562.5140.8982.0021.2432.42.43613.7326.0151.1940.2570.3120.1910.1910.7190.719
Bedrijfsresultaat -2.271-2.7562.562-2.408-3.473-4.52-4.59-4.46-4.059-4.013-4.229-2.926-2.356-2.514-1.942-2.002-1.847-2.573-2.436-13.731-6.015-1.194-0.257-0.312-0.19-0.19-0.737-0.737
Bedrijfsresultaat ratio 00000000000000000-50.865-6,089.191-11,898.244-7,518.308000-8,648.907-8,648.90700
Totaal overige inkomsten en kosten netto 0.0180.069-0.487-0.591-0.2-1.131-0.239-0.067-0.622-0.459-0.456-0.393-0.0590.751.806-0.0250.02-0.025-0.0240.1450.103-0.796-0.009-0.01-0.007-0.0070.0140.014
Inkomen voor belasting -2.253-2.6872.075-1.795-3.673-5.651-4.829-7.938-4.681-4.472-4.686-3.319-2.415-1.765-0.137-2.028-1.827-2.597-2.459-13.585-5.911-1.99-0.266-0.322-0.197-0.197-0.723-0.723
Inkomen voor belasting ratio 00000000000000000-51.352-6,148.711-11,772.267-7,389.03000-8,963.872-8,963.87200
Belastingkosten 000.24300-0000000-0.05900-0.0250-0.025000000.010000
Nettowinst -2.253-2.6871.037-0.898-1.83-2.833-2.414-21.162-6.917-2.236-2.343-1.659-2.415-1.765-0.137-2.028-1.827-2.597-2.459-13.585-5.911-1.99-0.266-0.322-0.197-0.197-0.723-0.723
Nettowinstmarge 00000000000000000-51.352-6,148.711-11,772.267-7,389.03000-8,963.918-8,963.91800
WPA (Winst Per Aandeel) -0.11-0.1330.059-0.053-0.11-0.23-0.22-1.977-0.87-0.31-0.36-0.28-0.46-0.34-0.03-0.46-0.419-0.64-0.6-3.34-1.44-0.76-0.22-0.53-35.58-35.58-130.76-130.76
Verwaterde WPA -0.11-0.1330.059-0.053-0.11-0.23-0.22-1.977-0.87-0.31-0.36-0.28-0.46-0.34-0.03-0.46-0.419-0.64-0.6-3.34-1.44-0.76-0.22-0.26-0.16-0.16-0.59-0.59
EBITDA -2.252-5.3641.317-0.563-3.472-4.52-4.50811.429-3.58-3.564-3.744-2.345-1.755-2.2691.44-1.391-1.198-1.947-1.601-5.137-5.204-0.814-0.236-0.236-0.169-0.169-0.698-0.698
EBITDA ratio 00000000000000000-38.489-4,003.59-4,451.761-6,505.505000-7,711.8-7,711.800